MediPress Health (Israel) Market Value

MPRS Stock   82.20  5.50  7.17%   
MediPress Health's market value is the price at which a share of MediPress Health trades on a public exchange. It measures the collective expectations of MediPress Health Limited Partnership investors about its performance. MediPress Health is trading at 82.20 as of the 3rd of December 2024, a 7.17% increase since the beginning of the trading day. The stock's open price was 76.7.
With this module, you can estimate the performance of a buy and hold strategy of MediPress Health Limited Partnership and determine expected loss or profit from investing in MediPress Health over a given investment horizon. Check out MediPress Health Correlation, MediPress Health Volatility and MediPress Health Alpha and Beta module to complement your research on MediPress Health.
Symbol

Please note, there is a significant difference between MediPress Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if MediPress Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MediPress Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MediPress Health 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MediPress Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MediPress Health.
0.00
11/03/2024
No Change 0.00  0.0 
In 31 days
12/03/2024
0.00
If you would invest  0.00  in MediPress Health on November 3, 2024 and sell it all today you would earn a total of 0.00 from holding MediPress Health Limited Partnership or generate 0.0% return on investment in MediPress Health over 30 days. MediPress Health is related to or competes with Nice, Gold Bond, Bank Leumi, ICL Israel, Mizrahi Tefahot, Azrieli, and Elbit Systems. More

MediPress Health Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MediPress Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MediPress Health Limited Partnership upside and downside potential and time the market with a certain degree of confidence.

MediPress Health Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for MediPress Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MediPress Health's standard deviation. In reality, there are many statistical measures that can use MediPress Health historical prices to predict the future MediPress Health's volatility.
Hype
Prediction
LowEstimatedHigh
80.0682.2084.34
Details
Intrinsic
Valuation
LowRealHigh
63.5165.6590.42
Details
Naive
Forecast
LowNextHigh
79.8682.0084.14
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
69.9274.2578.57
Details

MediPress Health Lim Backtested Returns

MediPress Health appears to be very steady, given 3 months investment horizon. MediPress Health Lim has Sharpe Ratio of 0.0996, which conveys that the firm had a 0.0996% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for MediPress Health, which you can use to evaluate the volatility of the firm. Please exercise MediPress Health's Risk Adjusted Performance of 0.0373, downside deviation of 3.49, and Mean Deviation of 0.9037 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MediPress Health holds a performance score of 7. The company secures a Beta (Market Risk) of 0.32, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MediPress Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding MediPress Health is expected to be smaller as well. Please check MediPress Health's coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to make a quick decision on whether MediPress Health's current price movements will revert.

Auto-correlation

    
  0.34  

Below average predictability

MediPress Health Limited Partnership has below average predictability. Overlapping area represents the amount of predictability between MediPress Health time series from 3rd of November 2024 to 18th of November 2024 and 18th of November 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MediPress Health Lim price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current MediPress Health price fluctuation can be explain by its past prices.
Correlation Coefficient0.34
Spearman Rank Test0.65
Residual Average0.0
Price Variance11.58

MediPress Health Lim lagged returns against current returns

Autocorrelation, which is MediPress Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MediPress Health's stock expected returns. We can calculate the autocorrelation of MediPress Health returns to help us make a trade decision. For example, suppose you find that MediPress Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

MediPress Health regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MediPress Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MediPress Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MediPress Health stock over time.
   Current vs Lagged Prices   
       Timeline  

MediPress Health Lagged Returns

When evaluating MediPress Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MediPress Health stock have on its future price. MediPress Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MediPress Health autocorrelation shows the relationship between MediPress Health stock current value and its past values and can show if there is a momentum factor associated with investing in MediPress Health Limited Partnership.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in MediPress Stock

MediPress Health financial ratios help investors to determine whether MediPress Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MediPress with respect to the benefits of owning MediPress Health security.